Associate Member, Broad Institute
On January 30, 2019, Elise Robinson will provide an overview of the role that genetic factors play in autism spectrum disorders and discuss the next steps to further understand autism genetics.
On 25 January 2017, Jeremy Veenstra-VanderWeele outlined critical challenges to translating genomic, cellular, and animal model research into new treatments for autism spectrum disorder.
Associate Professor of Neurology, Harvard Medical School
On 2 November 2016, Beth Stevens discussed recent work that implicates brain immune cells, called microglia, in sculpting of synaptic connections during development and their relevance to autism, schizophrenia and other brain disorders.
Professor in Neurology, Harvard Medical School
On 5 October 2016, Mustafa Sahin presented an update on translational research in Tuberous Sclerosis Complex.
On 7 September 2016, Ruth O'Hara discussed the field’s current understanding of sleep in autism spectrum disorder.
Bullard Professor of Neurology, Harvard Medical School
On 27 April 2016, Christopher Walsh reviewed recent work on ‘somatic mutations’ — de novo mutations that are present in some brain cells but not in all cells of the body — in several neurological conditions associated with intellectual disability and seizures.
On 30 March 2016, Catherine Monk described her lab’s fetal origins of adult disease studies that focus on women in the perinatal period and fetal and infant neurobehavioral development, including direct studies of the fetus, newborn brain imaging and placental methylation.